Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8463714 | Cellular Immunology | 2016 | 6 Pages |
Abstract
The development of neutralizing anti-factor VIII (FVIII) antibodies (inhibitors) remains a major challenge for FVIII replacement therapy in hemophilia A patients. The adaptive immune response plays a crucial role in the development and maintenance of inhibitors. In this review, we focus on our current understanding of FVIII interactions with cells of the adaptive immune system and the phenotype of the resultant response. Additionally, we examine both current and novel FVIII tolerance induction methods that function at the level of the adaptive immune response.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cell Biology
Authors
Maria T. Georgescu, Jesse D. Lai, Christine Hough, David Lillicrap,